Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: the GISSI-Heart Failure Trial
The GISSI-Heart Failure (HF) study reported benefits of n-3 fatty acid (FA) treatment on cardiovascular (CV) events, but the effects of treatment on a putative CV disease risk factor, the red blood cell (RBC) n-3 FA level (the omega-3 index), have not been examined in this context. We hypothesized that treatment with prescription omega-3 acid ethyl esters (O3AEE) would increase the omega-3 index to the proposed cardioprotective value of 8%. RBCs were collected from a subset of patients participating in the GISSI-HF study (n=461 out of 6975 randomized), at baseline and after 3 months of treatment with either an olive oil placebo or O3AEE (1 g/d).
Source: Nutrition Research - Category: Nutrition Authors: William S. Harris, Serge Masson, Simona Barlera, Valentina Milani, Silvana Pileggi, Maria Grazia Franzosi, Roberto Marchioli, Gianni Tognoni, Luigi Tavazzi, Roberto Latini, G.I.S.S.I.-H.F. Investigators Source Type: research
More News: Cardiology | Cardiovascular | Heart | Heart Failure | Lovaza | Nutrition | Olive Oil | Omega 3 | Study